Spinal muscular atrophy with lower extremity predominance 2A
Rare genetic disease
From Wikipedia, the free encyclopedia
Spinal muscular atrophy with lower extremity predominance 2A (SMALED2A) is a rare neuromuscular disorder characterised by muscle weakness predominantly in legs. The disorder is usually diagnosed shortly after birth; affected children have a delayed motor development, waddling gait, difficulties walking, sometimes develop spasticity.[1][2] Sensation, swallowing and cognitive development are not affected. The disorder is slowly progressive throughout the lifetime.[1]
Other namesLower extremity-predominant spinal muscular atrophy type 2A, SMALED2A
SpecialtyNeurology
SymptomsMuscle weakness in legs
Usual onsetInfancy
| Spinal muscular atrophy with lower extremity predominance 2A | |
|---|---|
| Other names | Lower extremity-predominant spinal muscular atrophy type 2A, SMALED2A |
| Spinal muscular atrophy with lower extremity predominance 2A is inherited in an autosomal dominant manner. | |
| Specialty | Neurology |
| Symptoms | Muscle weakness in legs |
| Usual onset | Infancy |
| Duration | Lifetime |
| Causes | Mutations in BICD2 gene |
| Diagnostic method | Molecular test |
The disease is caused by a mutation in the BICD2 gene and is passed on in an autosomal dominant manner.[1]
There is no known cure for SMALED2A.[citation needed]